<SUBMISSION>
<ACCESSION-NUMBER>0001193125-06-029040
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20060208
<ITEMS>5.02
<ITEMS>9.01
<FILING-DATE>20060213
<DATE-OF-FILING-DATE-CHANGE>20060213
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AtriCure, Inc.
<CIK>0001323885
<ASSIGNED-SIC>3841
<IRS-NUMBER>341940305
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-51470
<FILM-NUMBER>06604563
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
<PHONE>513-755-4107
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K - CURRENT REPORT
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K - Current Report</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="3"><B>PURSUANT TO SECTION 13 OR 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>SECURITIES EXCHANGE ACT OF 1934 </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report (Date of earliest event reported): February&nbsp;8, 2006
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>AtriCure, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of
registrant as specified in charter) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>000-51470</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>34-1940305</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>6033 Schumacher Park Drive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>West Chester, OH</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>45069</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Registrant&#146;s
telephone number, including area code: (513)&nbsp;755-4100 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Effective February&nbsp;8, 2006, our Board of Directors
appointed Mark Lanning to the Board and to the Board&#146;s Audit Committee. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">A press release announcing the appointment was issued on February&nbsp;13, 2006, a copy of which is being filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Exhibits. </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="95%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT><BR><HR WIDTH="22" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P><HR WIDTH="67" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press release dated February 13, 2006.</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:8%"><FONT FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">ATRICURE, INC.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">/s/ David J. Drachman</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">David J. Drachman</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman"
SIZE="2">Dated: February&nbsp;13, 2006 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT LIST </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="95%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT><BR><HR WIDTH="22" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P><HR WIDTH="67" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press release dated February 13, 2006.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px">

<IMG SRC="g69162image001.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Contacts:
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2"><B><I>AtriCure, Inc.</I></B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Thomas Etergino</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT
FACE="Times New Roman" SIZE="2">Chief Financial Officer</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">513-755-4561</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">tetergino@atricure.com</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><I>The Ruth Group</I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Stephanie Carrington /
Nick Laudico (investors)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(646) 536-7017 / 7030</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">scarrington@theruthgroup.com</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">nlaudico@theruthgroup.com</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Jason Rando (media)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(646) 536-7025</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">jrando@theruthgroup.com</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Press Release </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">AtriCure Appoints Mark R. Lanning to its Board of Directors </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>WEST CHESTER, Ohio, February&nbsp;13, 2006 </B>&#151; AtriCure, Inc. (Nasdaq: ATRC), a
medical device company focused on developing, manufacturing and selling innovative surgical devices, announced today the appointment of Mark R. Lanning to the Company&#146;s Board of Directors. Mr.&nbsp;Lanning will serve on AtriCure&#146;s Audit
Committee. The appointment brings AtriCure&#146;s Board to nine members, seven of whom are independent. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Mr.&nbsp;Lanning, 51, currently serves as Vice President and Treasurer of Hillenbrand Industries, Inc., a leader within the health care equipment and services, and funeral services industries. Prior to joining
Hillenbrand in 1988, Mr.&nbsp;Lanning spent twelve years at Ernst&nbsp;&amp; Whinney (now Ernst&nbsp;&amp; Young). Mr.&nbsp;Lanning, a Certified Public Accountant, also currently serves as Vice Chairman and a member of the Board of Directors of the
Indiana CPA Society. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Richard M. Johnston, AtriCure&#146;s Chairman of the
Board of Directors, said, &#147;We are pleased to welcome Mark to the Board of Directors. His depth of experience in accounting and auditing, financial management, capital markets, and investor relations makes him an exceptional addition to the
Board, and we look forward to his contributions.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman"
SIZE="2"><U>About AtriCure, Inc. </U></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">AtriCure, Inc. is a medical device
company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft and cardiac tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure,
Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial
fibrillation, a rapid, irregular quivering of the upper chambers of the heart. Atrial fibrillation affects more than two million people in the U.S. and predisposes them to a three to five fold increased risk of stroke. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">This press release contains &#147;forward-looking statements&#148; within the meaning of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements include statements that address activities, events or developments that AtriCure expects, believes or anticipates will or may occur in the future, such as earnings estimates, other
predictions of financial performance, launches by AtriCure of new products and market acceptance of AtriCure&#146;s products. Forward-looking statements are based on AtriCure&#146;s experience and perception of current conditions, trends, expected
future developments and other factors it believes are appropriate under the circumstances and are subject to numerous risks and uncertainties, many of which are beyond AtriCure&#146;s control. These risks and uncertainties include the rate and
degree of market acceptance of AtriCure&#146;s products, AtriCure&#146;s ability to develop and market new and enhanced products, the timing of and ability to obtain and maintain regulatory clearances and approvals for its products, the timing of
and ability to obtain reimbursement of procedures utilizing AtriCure&#146;s products, competition from existing and new products and procedures or AtriCure&#146;s ability to effectively react to other risks and uncertainties described from time to
time in AtriCure&#146;s SEC filings, such as fluctuation of quarterly financial results, reliance on third party manufactures and suppliers, litigation or other proceedings, government regulation and stock price volatility. AtriCure does not
guarantee any forward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or
otherwise. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g69162image001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g69162image001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`40$)`P$1``(1`0,1`?_$`-<``0`"`@(#`0$`````
M```````)"@<(`08$!0L"`P$!```'`0$```````````````$"`P8'"`D%!!``
M``4#`P,"`00*#0D)`0```0(#!`4`!@<1$@@A$PDQ011182(5\'&!H3(CM18W
M"I'1\4)2LC-S)+0U=CBQP6)U)M9W&!ER8V25U9871RA8$0`!`P,"`P8"!@,)
M#0D````!``(#$00%(08Q$@=!46$B$PAQ,H&10B,4%:%2DK&R,]-T5187-\'1
M8H*BPM)SD[,D-1AR0V.#HS1%92;_V@`,`P$``A$#$0`_`+_%$2B)1%JORGY+
M(<<K<MU^V@$[GN"Z91PRC(M=]\`U2:L&P.9!^[733<.`22[B:9`(F;510-=`
MZU.QH<:'@H$T7>./F;(O/..V%[,6!HAX"ZL=-PYER.?JV5;;>\DFN4`%5NJ4
MP'3,8"F$A@U`!U"H.'*:(#4+.%2J*41*(E$2B)1$HB41*(E$2B)1$HB41*(E
M$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB410"\\\F_G[FYS#M%Q6A<?L36^
MS`#@HD,DY4(YFG".WIHL9)`@_(*0U78*-\53<:E9-\;V30@LA7#C1^X.2/O"
M*-*1":A]$23L.HF)T$R:Z=]]'N5#"(>H-^M0DU%1V*+>Y36U14Z41*(E$2B)
M1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HBQWEF
M^6>-<;WE>[U4J1+?@9!Z@(B74[TJ!R,4R%-^&8[HQ/HAJ(AK40*FB@=`H"..
M&'GG);++^)G7SYHR&/D[INN89`F9PBJY7VHE(*X'(7XN27V^@B`!\U?0_P`@
M4@%2NF.VT]Q]S>L@)G*4ICF]5TTECDV*OHYB_413=`4-`!*7B3;RB`=2*ZA4
M0.9M?!0X%63K4N)A=MM0%SQBZ3AA/Q+"6:JHG!1,R;ULFOM*8!'7MF.)1^00
MKYB*&A57BNP5!$HB:T1*(E$2B)1%ZZ6EHV!BY":F'B$?%13-Q(2+]R<$V[-F
MT2,LX<+*#T(FDF01$?FIQX<46N&-^8.#LI7>-D6S<3HLVNHHE%%E8UU&MYLZ
M1!.H2,<."E(NIH0PE+T$Y0U#U"IRQP%5*'`FBV@J13+C4*5HBZ3?V2L?XKMY
MY=F2;SMJQK;8)F5=35T3#*'8)D)MW:+/5D@5,&X/HDW&Z^E??C<5D\S=-LL5
M;RW%VXZ-C:7'Z@#3Z5Y68SF&V_9NR&<NH+2Q8*E\KVL;];B*_`:J.*^_-'X\
M[$>G8FS.M>!B&*07%@6O.76R,8===CMDV(B<":=1`1"LJ8[H+U.R$?J"P$'A
M-(R-WU$U6$\O[G^C>'F,#\FZX<.V"*21O[0`%/&J_=E^:#QYWHLBB&;!M(5A
M*'=OJVIRV$$MYSD`5UWC4R:0!LU$1'0"B`^]0R'0;J=CV<YL/6'_`(,C)"?@
M`:J;$^YWHWEY!$S)N@<33[Z*2,#B-30CLXUIP4B&.<L8SR_`I71BV_+5O^WU
M@*))6U)MA,M"[R@<A53,UE3(',40$"G`HZ#Z5B_*X;+8.Y-GE[::VN1]F1A:
M?HJ-?H69L'N+`[FLQD-OWEO>61^W"]KQ]/*33X%9``=:\U>RN:(E$2B)1$HB
M41*(E$2B)1$HB41*(E$47GDGR:$9;5J8K9N!([N)0UR3*9#:#]5,%S-6`#H.
MNQ=XFL!@Z:@6JL3:FI4CBNS>./&)K:QQ/Y#?([7M^/FC>.,<H;RP4(5?MJ(F
MV`8$GSQV83`(F`11#TJ$CJFG8HM"P#Y(\5_5%V6WE:/1$K*YTOJ&=$@:%),,
M$-S%<YM`^D\8IB0-==>R(U/$_P"R>Q0>.U;3>/7)*=VX2;V<Z7WR^.W[N'VF
MZ&/"N5U'\0<A=1$2-T'/9$?34F@5)(VAKV%1:=%OKK][U^;W_P`E4U,OY.%B
M-D%G"HB"3=)1900#40(D0QSB`>X[2T11FVOS0GLM\DK(Q[9[,UO6&G,3;65,
M[324E[C,P:NB)_$";N)L69%T=Y2)_3,.FI].@U"P-;4\5*'$E2;Z_9^Q^W5-
M3)1$HBXU"B+H.5;'+DK'%ZV$9ZI&_G9;DI"%?IZB9HJ];'326$H"&\A%!`3!
M[EU"H@T(*@=0HQ\!\#<FV/EVW;OO*7@FUOVE*?6R!HAX=T^EEF^XS1$B9D2@
MV1.?051-UV]`#4=:J.D!&E:J4-[^"EVU#72J)-.*G6C_`#RYP8\X-8>6OZZ2
MA,W?<"[B#QQ9:!_Z7<=Q@R<NBJ.]INZT@8XB&YVXTT+N(F`[U"UD+IQT]R?4
M/._EMG]W8Q`/GE/!C*@4'>]U?*/B>`*Q1U>ZKX7I+MDYC(#U<E,2RV@'&23E
M)J[M;&VGG=V5#>+@JW''CBQRY\Q=\NL[<B<DS5K8)).N$DEV!%$&#DT8<S5>
M`QI;;@RL:BDP.B+9617[YB*E/O%4Y1+6U>Z-X[(Z%X]NW=KVL<VXS&-"=1S:
MA]P\>8DCS!@Y:BE`T+1S9/3[J1[FLN_=V];V6WVB)2`6U#3RFACM8C5H#=6F
M1W-0UKS$44ZEE^%WQZ6G!MXB0PLO?;I``WW!>=X70K-.3;0`16-;DE;<;H(]
M?HMBUKK?]>NI]]<&>*_%JP_8BCCY1\.=LCOK<5MMBO:YT7QMHVVFQ;KQXXR3
MSS%Y^/I.B9]3`L+YP\#/#3(<2]'&);OPK<PIJ#%.8*:-/VTDX,.X@24)<*+^
M1>-R"&@`D_0,`>XU<&W?<?OK%7#1E_0R%I7S![>20@?JO80T'XL<K6W7[0.F
M&;MW'`_BL7?T/(8Y/4B!/ZT<@<XCX2-/BL2>%S!N1>*F9>7/'')J;(EPVN%F
M7$W=L%U56<U#2BKYK%3L>54"&!C)-F^XNI=Q1U*(]*]KKWN#%[RP&$W7B"[\
M--ZK""!5CVT+F&G:TG77Q5M^US:F;Z>[HW)L?/!@O+?T)`6DT>Q_,ULC:_9<
M!4:5[%86U^[U^S]BM8UNBN:(E$7&M$34*(FM$34*>")J`5"J>*:A]GV?/44\
M>Q-:(FOVZA7ZT36HHN:(E$7!C`4IC&$`*4!,81]```U$1^8`HBKHY[N:0Y!\
MDY-O$"=RE*W'&V1;943=T`C6[HC`'2)2]`!3>HX,4->NO6OH:.5FO%4SJ=%8
M'LNU8^R+3MZTHI,B3"WXII&H%3+L(;X=("JJ@7][WUA,<0^4U4":FJJ+%')W
M&:65L+7C;)2%-(MFGU]"'$HF%*5ARG72$A2AJ*BS05D2_.I46FC@>Q0(J%#Y
MP8R2KCO/$3!OCF;QM\B>T9)(QP(5.3W+#&"L)AVE[#\@E-KUZ^U5I!45"D:=
M58!T^S]VOG511^WER%Y,1DY>$.QXY.):V6CR9CXB93>K-UG<6D==%O(K$,95
M/51L`'$I0`-?2J@:TZU4A)45.`;HG;4SO;ET0EHOKPG&<S-.2VDP=ILWKU5R
M1Z#IJ@[61<)D4:BH;J8AM0+55^K3W54HXJ9J/Y"YK<D,HZXDY`:$,4AT>W=M
MO.14`X:CN*9FV%+37W`1&J/*WO52I[EWJ^<S7I9V.8^_$\,7)*.SL7\C<-LF
MG(V/>VPT8%$QCOGGPSQ!<ZI"B8"IEZ%#7YJ@!5U*I4@5HM+L9^0=_>=^.#W=
M%P=D8\A[=E)9RFDX4D)A^Z0(F+1H5PMV$3JJF$"ID3(41,;J.GI.8QV<5+S=
MZZ9='D+S%*N%9+'^*F[&TB&4^'D)1G,S"KA,PF%%9=ZR1;1R0*)EW;2@(@(B
M&X=-:B(VUU4"X]BVSMWE3/I8*M#+=R8TGYU.2MYW-W+(VB#8(&&38O7C9<RI
MGKD[Q/:1N`F`"'TZ]?:I2SS<H*G!TJL3XHYO7#FW.EH61!6NWM.SW82)Y#XQ
MX25F)([9@[63U7(V;-V;?>0H@0A1/KKJ80J)8&M/>I0XDJ2P?7Y^GW]?M?)5
M+Q4ZHH>1S,,_S8\B;C'48_44M>WLD1^"[%:D[BB+<K>X$(*X9#X8J@E!V]ET
MENX)!`1(B34>E=%>EF#MM@]+AE)6@7DMJZ\F.E3Y"]C:TX!M*=Q)7(_K=N:\
MZI]:W86%Q-A!>ML+<:D"DC8WOIWNDJ33B`-5=GP_B^VL+8OL3%-G,TV-N6);
M49;L:B0A2"<K)`H.'BW;`"G=/W9E%UC>IU5#&$=1UKG_`)W+WFX,Q<YJ_<77
M5S*Y[C\3H!X`:#N``753;.`L-K;?L]NXQO)8V<#(VC3[(U)\7.JX]Y)*R2`:
M5Y07N(-0HBQLQQ19L;E2?S*T8JIWS<UH0UCS$A\0<6[F`@9!U)QJ(M?Y,JR#
MEX?\9^$)1TKU)<S?RX:/`R.!QT4[YFBFH>]H:[7N(`T7A0[<Q<&X9MT1L(R\
M]JRW>ZIH8XW%S13O!)U[E"5SI\SU_P#$Z^+EQ"CQ6DXN\"LE'UGW=>U\,C0$
MO$'<N6C6X2VW#PQGRC5P=L8R:8ODS!H&[W"M@>G?0;&;TQ\.<=F6OL*TEBBB
M/.UU`2SU'NI45%3R'P6JW5KW09CIWEI]M-V^^+)TK!-/.#&]A):)1$R.I!IH
M#(#PJI4N$&5;PS?Q9Q!E:_G35Y=UZVX>8FEF35-DT%PI(/$RIMVR0`1-)%),
MI0]Q`-1ZUAWJ#A;';V\;[#8T$65O+RL!-30`<2>WM6P72?<63W9T^QFXLPYK
M\E=0<[RT!HJ7'@!P`&B[OR-RK>^&<6S%_8_P].YRGHA5)0]BV_/Q]M/E8LJ:
MZ\E*C+23-^V21C6Z(F$G:,934`#3UKS]K87'9_+LQF4OH\=:O!^^>QT@YM`U
MO*T@DN)I6NB]7?&X<KM?;\N8PV,FRUY$0?P\<C8G<FI<_G<UP`:!6E"3V*!+
MC_YL<L\K^7N#\/6IC2W\58XNRYWZ-PE=2AKNNJ38MK?FGB#$TF9A%1[1'OH)
M',9)L501)Z@`B%;'[FZ`839FR,AG+VZEO<K#"TLHWTHVDO8*\M7..A.A=35:
M@[.]U&XNH?4K$[9QMC!C\)<7+A)5QFE>T12.#><M8UHJ&G1E3W@:&PKE^\[N
MQ]8$W=-C8TF,NW1'D1^J["@I5E"2$TJHH!1(65DDG#1DFD7Z1CF3/T]AK63!
MX^RR>2CL\C=QV5FZO-,]I>UG^*T@FO=4+<_<V4R6&PTN0Q%A+DL@P#DMXWMC
M<\G_``W`AH'?0JLO=?G-Y!7MR)Q_B&'QI:_'VUS9BLNS\A*7#*%NVZXZ,&\H
M^*NYD]EUFD7!,D"1YUB&63;`=(-3@?H`AMK9>W?;6/VO=9JXNILI>?@)980Q
MOI1N=Z1=$0T%SW$FAH74/`CBM#LC[M=XY/>MGMNWL;?#6/YG!#<>H[UI6,]=
MK)FND(8QH#>8%P9IQ#EDWDUYS,C3%QSMB\(L,R-\Q]N.7$=+92E(69N4CQPB
M/;%:#MJ`:*IL6@*)',59VNKWR"4P)DZZ^/M+V\8R"TCR&_[]MO++0MMVO9'0
M=SY'D5/`$-`H:ZE7!OOW9YJYO9<3TKQ<EU#"2UUTZ.27F(TK'%&*-;QHY[CS
M"AY0MZ_$/S$SCRVQ[E];/R;=*],<7C!0Y4DK=/;+E-C.QLB_33=QQRIF[A!9
M:`(D*.GRUCSK?L7;VRLG8MVU4X^[@>[5_J`ECFBH=KW]ZRW[;.IF[.H^%R3M
MX!HREC<QL_@_2/+(USAS-[_+IH%T7R`^8^R>+5TOL*88M5#,6<$%&D>_3^/.
M%IVE+/Q1,WC'Z<:DYD9^<,18A?@FYD!(HH4#'$P&)7H=,^A-_O&R;N#.S&QV
M\:EOEK+(T<7-YB&L9H?.:UIH*4*\CK'[G,3T_P`B_:NU[<9/=;2&N\WW,+W4
MHUP;5TDFH\C2VA(J:U"TC8O_`#W\B8L]Y13J/Q+;TVV,ZB;?<DC;/<)L#%!9
M`[0J4=)RPBY*.J9G"I51`=!T"L@21>V_:TPL)PZ]NHS1T@YI=>!KYFMH.WE%
M%BN*7W>[VMSD[=PQUE*VK(SR0'EI44'*]^O87.K\%B26\BGE5X#7C"LN6-GH
MW[9\LN4K1.YH]LR:2S=N`%>$@+VA6XG)(BEU*1T0^A@W=L0W5[</2_HWU*L9
M)-ES_AKY@U],DEI/#GB>=6U[6D=U:T5MW/6SW!]'LE%#U%MOQ>-D(IZK0`\#
MYO3GC;HZFH#@[A\M*JS)Q;Y/8PY;XC@,O8ND3+Q<HBDC,0SHZ8RUK3Q$2&D(
M"733$2E=L53"4#AH54@`<``!T#4S>&T,OLG-RX/,,I,PU:\?+(S[,C?!P^K@
MM[>G^_<#U'VW#N3`/K;R`![#3GBDIYHWT[6GMX$:A;%U:ZO9*(M?>4F0PQG@
MK(-Q(.`;RR\*M!00@82+#+3QB1+=5OH)3"JR(Z,XZ#KM1&IFBK@H'@HO?'?C
M#\[<HRN09!MW(VPT"F:J'+J12X)0JQD^V)BB(K,D-%!]!`%0^6JLGE%%(T5-
M5)%R-YF\;>*#.-<9RR;$6B[F2K'B((B3N7N.21;[>^X:PD4@[?BW2$X`*AB%
M*(CH`B.M71M;8>Z]YO>W;MI)/''3F?HUC:\`7N(%?"JL3>_5#8W3N)C]V7\=
MM)+7DCH7R.`XD1L!=0=Y`"]AQ[Y<\=^4\4ZE,'9,@[U&/127EH='XAA<$0FN
M.U,9.#D46T@V*(]!,)!*`B`".HZ52W/LG=&SIA#N&TDMPXD-<:%CB./*]I+3
M]=56V7U(V5U"MW7&TK^&Z+`"]@JV1@/#FC<`X?&E/%0Q<JK%<X<Y$W.,.D9F
MP<3#"^;84(`I)D!\9&4411,3:(E:2A5"&$-!JWF>8*]':'3O4[N%L@M<I8PL
M^]VRA5#S,2B+X`Z"G*-!%I(D.3KL'XM`QB@/788!]Z^<BAH55!J*K($Q_9$K
M_JU][_\`AE:#BBKY\2=?^:^S].G^TMU>_P#H2?R=*K/^4JFWB%8>^SYZH*HL
M89K_`$1Y'_N=._U!;7[U1&I0JO7QEQTRRGF6P[0E4A4B'#P)&6)J&BC&+0^-
M60.)P'Z+D$NV.@=0-I7T/(#=.*I#BK*+2&B(^.2B&,7'M(M!(B"4<W:-T62:
M)"`F1,K8B8(@0I"@&FGH%?-4JJL1YUCV$7@/*[*-9-8YDG8%UBFT8H)-6J?<
MC'1U.V@@1-(@'.81'0`U$1'W&IA\P^*@=`H5N#?^).R/YN8_);NJK_E*D'%6
M`IM5=&&EU6V[XE*+?J-]H")N^1JL9'8`>INX`?=J6W#77#&N^4O`/PJ*JG=N
M<VUE='_""-Q'QH:?I5`GA:1"5\F>.%+A$IE5N1-T/G?Q)MIOK<+CG7114WZC
MWAD0UT]=U=*=^\T/22[;:Z-&+C`I^KR,'U4_0N/'3,"YZ]6+K_YW9ESC7]<.
M>1]/-2B^@6'[?^6N:*['I1$HB_(^W^>H(J8WZPK_`(N[*]/T/PX?=^M):M\O
M;(#_`$'N#V?CG?O6KE[[SM>IMH/_`*Z/]^]61_&'_@1XY?W')^4G]:K=7?[1
MLK_*/\T+>'H%_9#@_P"2?YSEN%D7]'U]?W.N?\B/JL7%_P#,[;_7Q_OPLG9O
M_DUW_)9?WCE09\4H@'/_`(V^F@73*ATZZ?[*3W0*Z2]9C7IIE>_T6_[QBX\^
MWC^V;!_RE_\`N95]!?4/2N9979E?.%Y(P#N[>8V6;68_2?W-G&9@&8:]!<S%
MS!'(#U_[UR'VJZI;5N(K/8UE>2#[N''L>?@V/F/[BX?[XLY,AU.R./@_AI\M
M)&W_`+4DO*/TE?0$XZ8(QUQXQ+9..<=6S#P$?!6S$,7KN/CFC1_.2"3-(SZ6
MF':"*;B0?OWISJG.J8PZFT#0``*YG[HW'E=SYJXRN4FDEDDF<0"XEK&D^5K0
M30-:*``+LGLC:.%V7MRTP>$MXH88;=C7%K6M=(X-',]Y`JYSG5)+C77N6N/D
M>SVVXB<1<O9;M5A'Q-ZSI8NT+?D&+!NV7<79=*YHN,?R"S8B*[E2.:'75(<Q
MA,GMU#WJZ>E>VG[WWO8X6]<Y^.BYI'@DD"*,<SFM!J!S'E%.!5C];]W,Z<=-
M\GN+&QLCRTP;#&YK0"99*M:YQ%"2QO,ZI.E-%4N\5F3>.EA\LW6;^6UWM63:
MV(:>N:V']P1[V?\`K7)4PY*U^MGI$FKTZSMNSDGCE-0X"8KHJ9P$#%`0W6ZQ
MXG=.2V4-O;*@)?,]C)&QN#.6W:*AH)(T)#6D#[-6\%SD]O6?V1B.HSMU]1KE
MK6P0R2Q.D:Z3GN7D#F<`'5+6N>\$_;H>(JK3W_6%\>@__?L=_P"WKF_]*]!K
M3K^HSJ?V8U_[<?\`I+H-_P!3/18__,,_V4O^@M<^6/D(\9O)G`.2,17+F:!E
MAN2VY,EO*NK6G5EX>Z4V:QH&8CE7$3_1'K)_L,50HE';N`1T$0&ZME],NK6T
MMRVN;M+"5GI2MYP)&>>.HYVD!VH+:Z*R.HO6CH/OO9U]MR_RD,AF@<(R8I"6
M2T/IR-)9Y7-=37^XH:?`OR#E\:\N3X:<22Y[/S=;<Q&EB!54%M^>ENI)SD-*
MI(B;M$<%A6,@D<VW<<J@`(_1"L[^X_;$&6V1^?-8!?X^9CN:FOI/JQ[3VTYB
MPCL!'BM8?:#O.XP?4D[9?([\LRT#V<FM/7C'J,>!P!$;9`>T@CN"NM5H&NIZ
M410]^2S)@NYFT<4L'(BC%I%NB>0)H)3O'156\2D<0U$%4D-Y]H^RI1JM$/M'
M@I'?I6Z7"_&'_P`9X,MY%TW!":NM12[)D3%$BW<D4TDV*2H"`&(=O&H)$$H^
M@ZU)(:GCHIFZ!4<_))?=^9`YJYY?Y#7>A+1%YOK=C8YZ97MPD%%Z$BX]B@II
M\,T[)^\!0#03*B/76NG?2G'8S&;`QL>,#?1DMP]SA]I[OF)(XFHIKW47%?KG
MF,QE^J68FS)D_$Q7;HVM=7R1MT8UH[&T-:=Y)[5V[Q3WY?MB<[,%&L-R^!Q<
M\^]M>X8MH)A;SMLOXAXYDF<@B`[56S8[%-T`]#%4;E$!TU`?BZRXW'9'ISDO
MS$-Y88Q)&X\6R!P`([B:EOP<5Z7MXR^8Q'5O$?DSG\\\QBD8.#XG,<7M<.X<
MH?\`%H5N;R/XO"=L"&R<P;`>0LUV2.EE2%,94T#(K[4Q,`>B#-XJ*AS#Z`-<
MTHCKRKLH_O"ZCXT\G`O%WCBB0<_C6+L+K@$3F$QC-WB2#*713,(=$T%6J)P(
M`Z:J&$`]1J:5M->U&E2C3/\`9$K_`*M??U56J0XJ=5\^)(__`*OL_P#O+=7\
M22JN_P"4JDWB`K#U?.JJQAFK]$>1_P"YT[_4%JF;\P^*@>"A0\?31-SR#@U5
M!.!F=NRRZ0`(;1.*":([M=PB7:J/R#J%5I.!4C>*G^KYU46'>0OZ#,M_\/[H
M_)3FHM^8?%0=P4)/!K_$E9'\U+_DMW59_P`I4@XJPL8H&`2F*`E$!`0'J`@(
M"`AIKU`0&OGU53CIV453+D?R9XB\+^95R6U+^.B%:WO9N0$+MB<I-LK78U7E
M2S,B$R2^V$0<[AF`.%7BJHMQ`4P4*9/3:&E;I[5VGO??VPXKJ'=,AQUQ;&)U
MN;>(AO*.7T2[0Z``<W&E#Q7.G>^^NFO2_J;/97.RX69>UO!,RZ%W."_G=Z@G
M:S5OF))Y?EJ"TT"M06!?%NY*LBU,@VD_1E+:O*`B[CA'Z!A,FXCY9HF[0'J!
M3%4(53:<H@!BG*("`"`A6G62Q]UB<A-C+YI9=P2NC>T]CFFA_OCP703#Y:RS
MN*MLSC7B2PNH621N'`M>`1^[0]QT7;Z^)>DFM$7Y'[GW?N5#BBK<>7CDKQ8P
M_P`A+;MS-G#&$Y"W*ZQW&R#2[I'(=PVHLRC%7TBFE$%CXD0;J)H*)F-W!`##
MOT]JVLZ([4WCF]L2W>`SS\79-NG-,0@CDJX!M75=KJ"-/!:.>Y#>_3S;N]H+
M'=>V(<SD'63'"9]S+"6L+G`,Y8]#0ZUXZJ9O@_=MG7UQ6PW=E@6"AB^SYJUR
MNH.PVLHYFT+;:"]=$!BE*.Q,Y>%`Y1-N..OTM/:L#=0K*_QV\;^SR=R;R^CF
MH^8M#2\T&O*-!\`MG^D^2QF7Z>XS(X>S;88V6WK';AYD$0YCY>=VKM:G59]R
M#,Q%O6+>,Y/)IKPL5;,V^E&ZQU$DG3%".<'<-%%4BF52*Z3`4Q,4-Q=VH5;>
M,MY[K(P6]L:7#YF!I&I!+A0]VG%7EFKFVLL1=7=X`;6.WD<\&H!:&FH)&HJ-
M/I54O@7R\X67]RTPO:../'Q;N*;SFYU^W@<@,\K73..+97);\JX4=IQ3\P-'
M@JMD3H[3=`[FH=0K<OJ/LG?V.V3?WV5W-+>8^.,%\+K>)@DJ]HH7-U%"0:^%
M%SRZ0]1NE66ZC8O&X+9L%AE99W".X;=SR&(B-YY@Q^AT!&O?7L5N/3]W]FM)
MJ+H^JA<[RVX6+\S5,?#X[+<E,A.N0,7:J5_GRW=+=TXNIW>C*-:W.,9W`8IJ
MED5B..SJ">H;1Z5N_;[*W\S80R7]*)F8MN,=(81;1D",1%QCYOF(Y12O%<V+
MSJ/TJ=U0.'_H7;R9Q^9;$+C\9,"9C.&"7DIR`\WFY:T["K=S;3X=`03[1>PD
M()`(&!,.V7\7N_?;`Z:^]:1.KS$5KKQ722.GIMH*:#Z-."B[\N64<4XBXP1-
MTYFP(WY#V2IE"UHQ6S'USRUIL6$LZ9S!XV><2428%E#-3HF332/J0QE=?4`K
M+G1/$9K-[N?9X+)'&9$6DA]41MD<YH+`Y@:[36M2>.BP)[CLYM[;^Q([W<^(
M;F<5^/C:872R1-:[DD<V0NCU-*%H!TJ?!1B^.9+QQ\][ZOJP5N!UHXQE[1MM
M"YV95,CWM<8S#$7[>/>"5,LM&F;_``BSQ/K](!WUE[JD>JG3?&V^2_I'/=P3
M3&,_<1,Y3R\PUY75K0]RP%T4AZ'=8,O=X<[2M;&XMH!*/^*N).=O.&N^VPBA
M([^*EZ_Z4?CU_P#YCL[_`,\OK_>NL(_US=3OYWG_`&(OXM;(_P#3KT6_F&V_
MVEQ_'+C_`*47CUTT_P"6*SON3E]?[UA4?ZY^I_\`.\_[$/\`%I_T[=%JU_(+
M6O\`K+C^.7>\9>/'AAAN^;?R5C/`ULVG?-K.'+J`N%C+7:X=QKAVQ=1CA5)&
M1N%ZS.99B]53'N)G#0XB'70:\W+]4-^9W'R8K+Y*:;'S`!["V,!P!#@"6L!X
M@'CV+V<#T5Z7;8RT.=P.'@MLM;DF.1KYB6ES2TD!TCFZM<1J.U;I582RBO"D
MG[>+CWTF[.5-K'M'#UP<Q@(4J+9$ZR@B8P@4/H$'UZ415[8(KOD]RX:+O04=
M1MV7\5Z\`FITT;.MPO=%(-Q3)H[X"%*GKIM%8_IUTKZ#Y6>"I<7*PP@@DV;H
MMD"%3102312(0H%*1-,H$(4H%T``*4/:OF-5543/.7Q"8(YH7<CDX9^X<4Y/
M%O\`"S4]:K>+=1=VHDV@V5N.)D&2PJ2#,HFV.$%$E#@(%4W@!=,U=/.M^Y-A
M6)PXCBO,16K62%P=&>WD<#\ITJT@CNIJM<^K'MMV?U0R7Y^99;#/%M'R1AI9
M*-*&1A&KAJ`YI!(-'5H*>ZX+>)K`W"6X'.0H^6G\FY2<QYXUM=EW(12;>VVS
M@R9GQ+7C(]BV(R5>=HI3.%3K.`3W$`P%,8!H=1>M.Y.H%J,7)''9X</YC'&7
M5D(X>HXDU`KHT`#M()"^GI-[=-G=*KUV:MY)K[/N9RB68-I$#3F])@`Y2ZFK
MB7.H2`0"0I);[M*/ONS+GLZ51(NPN2%D(E<A_P`$/BFYTTE/F%);:<!]A"L.
M@]O:M@J5&JKS8EN.5X^<BH521.=L%N7B%M7(5;>@DI"NWI8N2<K$U`1138+B
MY3`=0U*4:^BG,**2M"K',@B=U'/FZ0ZG<,W2*0Z]!,J@<A-1^34P=:^<*HJ]
MG%DZ<5RUM1&053;'3O2ZHT16,"0"],M*MB(%W;=5%5R:%`>HC5=WRGN5(?-X
M45A9\_8QC55[(O&S!FB`"JZ=KIMT$]Q@(4#*JF*0!.<P``:ZB(@`=:H*JL<Y
MG.13$&1%$S`=-2S)PY#E'4IB'CU3%,4?<#`.H5%OS#XJ!X*%SQY_I^CO[K2O
M\5O59_RJFWBI]*H*JL.\A?T&9:_X?W1^2G-1;\P^*@[@H2.#8@').R`$0`>W
M+AH(@`B/U6\Z`'N-5G_*53'%6&:H*JH2/,;X['?*[';'+^*(XBN;L8M7)E8U
M),@*7W9)&RZSR#*)2@LI-QKE))9CU,!B@JEMU4*(;`="NJ+-F95V#S3O_P`_
M>.%''A#-4`/[@QPJ'_0:Z+5/W.=$Y>HF#9N;;L8.Z[!IJT<9X*$N9XR-(!C\
M.9M*N!$)_C7\LUY\+U$\%9OAYFY\*MYA^3MKD?EO?%KU=50[YK&,7A@[\01_
MO46CU$R*$54,)#EZ@.?^J_1?'[]KN+;\D<.X"P:BGHW`^R7$<'<M`'@D$`5!
M6K'0WW%93I:X;2W9%+/M42.T/-Z]JXGS!C7<6<U2Z,@$.)H1P5K;$/.7B9G"
M#;3F/\[XZ>)KH@JM&2US1,!-1YP*0RC5_&2SMJLBZ1!0-Y2[M-?40K3/-]/-
MZ;>G-OD\==-(-`YL;GL=XM<T$$'Z%T/VWU9Z=;KM6W6'R]DX$5+'RLCD:>-'
M,>6D$5'>O9Y,YH\4\0Q9I>_\_8NAFO;.HFFE=T/*O%]FT-B#.*=/'!E#F,`%
M`2AJ(U1Q.PMY9R;T,;C;Q[ZC4QN:!\2X`+Z,YU0Z>[<@_$9?,8^-IX`3,>X^
M`:PN-=131:-\:O**;F3RQ:8DX_XREG6"+:M>Y9K(.7+ACY!!T$FT*V2MR/CT
M$CDC8="2=+"&UP*ZZY0`4]@`:LA;MZ0#8FRW9G<UVQNXIIHV0VS'-IRFO.XG
MYG%H'V:-'`UT6)]B]?3U/ZB-V]LZQD=M*"WD?<7<K7!W,!2-K0/)&'.['<SG
M\6T`*BC_`%BW&TDRRKA#*B;(YX:X;3D[0<R)4E!11E(EV=\U8+K;>T"SAHNH
MHF77<8J9Q]AK,_M<RD,F&R&'+O\`B(YVR!NFK7"A<!QT(`/Q"UU][."GAW%B
M=Q!I_#36SH2ZF@>QW,&D]Y:20/`J7_P\9ELJ]^">(HE"[H%6Y+'0GK6N:$4E
M6"4K#.8^8>.VI7;$RQ'"2"T.\0634,788I_41`VF#^NF`R&/ZC7TSX)1:W!9
M)&_E/*\.:`:$"GS`@CP6ROMEW1B<MTBQMNRYA-]:"2&5A>T/86O<1S-J"`6.
M:X&E"#QXK#GEUYYV9C_"-P\?,/7/$WSG'++)6WW$):3Y.<>VA:2R9S34W(GB
M%5P8/#))]M`BA@$-3&,`%`-?=Z(].+_)[ABW-G8GV^WK)P>'R`L$L@^5C0X"
MHKJ2/`!6U[DNKN,P^TY]F[8GCN]UY%OIED+A(Z&(UYWNY">5Q`HT'Q)T"K<^
M)1@,CY"N-[0BR2`_G%<;GNK&*5/8RLFY'9B:B(`)U2H[2A[F$``-:VKZURB+
MICE7EM?NF#3QEC'9W$U*T9]N$)GZT8-@('W\AU\+>4_W*=Z^@/\`=^U7-%=E
M%\^^3:.6'E+CFKQ$S=PGS,L\YTE-`,4JV3X-9(P]1``.DH4P?,-=,8GMEZ//
M?&:M."EU^%N\?NKC+<Q20^X*)DH+7C<\.GQNV$?H(*^@6A_((_S*?\0*YGO^
M8_%=F(_D'P"U.YR\;&'+'C%DW"[H2IR<U%I2UIO#%W_`7?;ZP2<"Z`O0#"9R
MCVAUZ;51J].G>ZY=E[OM,^W6&-_+(.^-_E>/J-?H6.NK.QH>HNPK_:[S2XEC
M#X7?JS1GFC/TD<I\'%46..N:LI^/OE=&7F>(=LKIQ?<LI:V0;)D3.F)9J&6(
MXB+A@GJ8]HX]YDX%TR4,4R8."(+;3%``'HENG`8;J9LUUAZC76=Y"V2&5M#R
M.T<QXX]HY7#C0N;H5R2V3NG<71GJ)'DW0N9D+"=\5Q`ZK1(S5DC'<*@@\S#P
MY@QVHT-X+C9Y".+')ZT8ZXK)RI:D-,K()C,V1=L[&6_=$"]^B59HZ823EL9R
M`'-^+42W`H30V@=0#GONOICO+:-\^UO[.:2WYO++&QSXWCL(<T&FG$'@=%U?
MV-UFZ?;]QL=]C,A;Q71;YX)I&QRL/"A:XCF%>!%:C719YO#D-@>P(AU.WGF+
M&MNQ3-$Z[AU(WG`)[4DPU.8B!'QW*^T/4"$,-6[8[8W'DIVVUA8W<LSC0!L3
M^/QI0?25=V3WKM##6SKS*9.Q@MFBI+IX^'PYJGZ`5I-Q;\DUH\PN3]^8CPK;
M3B5Q'CJQ7\W*Y7>(ODOKNZ`G8:,BH^(0`"M&L0\:.'BJ9EMZSDJ`'(!"@8*O
M_>'2B\V+M"VSF?F#,W=W+6-M@0>2/D<YQ<>)<TA@(%`VM#4T6+-@]<L=U+W]
M=[:VO;NDVY8V;I'W;@X<\OJ,8UK!P#'`O(YJN=RU%`"I/*Q&L]+33G5DL,?8
M)F6#1<B<U?#IM:T<3<8JOPS@X+2[E$2^AVS!(PAKZZU/&*N4KCHM7_&GBXP#
M=V6WZ`[3`:T[?5,4-#%`4',NL41T'Z(D23`0]=3!K\L\AIY5!H[5+75%3I1$
MHB410D^1##DG;^1$<JQ;`QK9NY@R:R[M)/4C*YF7?;&^)V@`$(_CRM^V(^IB
M&JM&[2G:J;A]2W#X>\JK;R3:,18UW2K2*R'`-&\:1%ZY,4;F9MD@21DFJRQ2
M$,[$I-%D]VX#=0U`:E>VAJ."F:5C_.7`-Y=]\.\@XIO%A:LI*2AYEY%RS=TF
MS929U"KJ/HN1C`5=)'67$Q]@I!M$?PAUZ1$@IRN&B@6]R\FWN&N:KGF(-QG+
M.B]Q0%O/V+YO;\&#]RC(A'KHN$&[Q9^$>FD7N(A],4ES!ITZCJ#G:*AH3E-5
MM;F^Q\J7M::EEXVN*U;7BI2)7B9M_.LW[^2,U5(#<$(TK78@@(MPT%0^X=1Z
M%]ZD:0-2IB"5H]BW@GFG$-XQE[6ADVR4Y6,!1(J+R)EUV3IJL3MK-7*113.9
M-0GR&`0'0?:IR]IT*EY2%*/`EFRP\:6Y#QRLZ5H@665B2K%C57Q4R@NJS(Y*
M"Z:"B@"8I3:B4!TU'36J2G6$>05A98R9:[ZRK!N6U+9@KABGT5<[J:82#V5<
M-GA>T9O&*-3$09E.B(@8Y@.(ZZ:>]3-(!J5`BHHM%;!X`YBQK>,'?-K9-LM"
M>MUT+N/.ZB95PU.8Z:B"J+IN`IBLW605,0Y0,41`PZ"%5#(TZ=B@&D%2J6Z2
M?)"1I;I5C%[@*U(666AB+I1BKP-04.S3=:KIH']0*81$/E&J)IV<%,O<Z=?W
M/O?<J%$497,/Q1\7>7SF2NJ:B'>.,H/DPW9#LE%FBY?."%(FDM<4,L0C2<*1
M,O711NJ<PZF4$?7+>QNL^\-CL990/;=8AO\`W,I)`'&C'#5FO@X>"P-U+]NW
M3_J5(_(743K'/O'_`+B``%QX`RL.DE!XM/\`A*&VZOU;N^228DM+DA:<M#BM
M]%Q<]BOHN2*WUUU%M'2TPV,J4.FG=`!T]JSM9^ZG&F*M]BIF3TX1RM<VOQ<U
MAI]"UFOO9'G(KBF(ST#K2O&2!['4^#)'BOTA9KQ'^KCXXA9)I)9ASS/W4Q2,
M(N;:LFT6%JE7`#B/T;C>RTPN4#D#00^"Z:CUJWLS[ILI-"Z+!8R*&4C1\LAD
MI_B!K1_E*Z]O^RC$Q3-FW3FKBYA'S10Q>G7_`,U\DA_],?%3[X,X_8DXWV.S
MQYANS(NS;::B559!DD!GDD\`A4SR$L^-^/?/5`+J)S#H&H[0`.E:V;AW+F]U
M9$Y3/3ON+LB@).C1QY6C@!W+<#:6S=M['Q+<+MBUCMK%IJ0WB]W:Y[N+G'O/
MT477>3_&'%O+;$TSB#+,8L\@Y)1%]&R;$Z:,S;DXS-O83<,X535(B[0'4A@$
MH@HB<Y!T`VH?7M#=V8V3FH\YAG@7#*AS37E>P\6.`[#Q'<0#V+X=_;"V_P!1
M]N2[:W'&76DA#FN;0/B>/E>PD&A'`][21VJO3*?J[V1K>GUE<7\L4F$&[6[;
MAR_M25@)L&!MVJ*A8*XG3=\=(IQ*&Y1,IPU'0NNE;.P^Z#%W5M3+X4NN6\`)
M&O97O\\8(^HT\5I=<>RK-65Y7`;A#+1VA+HGQOY>[[N4AU*GM`/@M^^./AIQ
M9QPQ[E(&5WN<C9PR/9$S:*.1[IB$8^-MI.90*5S]3PK=W)N4#KK%#O.3N5%E
M"%```O77&VZ>N^8W1E+(O@%KM^UN&R&&-W,Z0M.G.XAH-!P:&@#Q68]D^V'`
M;(PN0$5TZ^W7>VDD+;F5G*R(2#S>G&'/(J?F<7%Q'<H\,5>!GE9A;(-JY1Q[
MR2Q7$WG9DD26@GI[>N59%-V1,Z)DUTA(7NMG""ITU"]!$AQT$!K*&9]QVR\_
MC)L/E,3>OL+AG*\!\8-/`UT(.H^"PIM_V@]0]KYFWS^%SF.BREK('QN].4@&
ME#44U!!(/@585G(CEFMQ^MJ'M^YL.LN2'U3$,[MNR1C;D>8X^LR)"E.2L##I
M%;S!^^?11LDL<@)F'0QC`'76&WFV6W<\T]U#?NVISN,4;7,$_+6K&O<:MTX.
M(K7L6Z-W;=1G;-@M;*XQC-\>DQLTSFRNMN8#SNC8*/->+6N(H>)*KT/_``*\
MJ9/)BV7'?)7&![Z7O`E]C,!`W.!R7&E*DF4':9-HB4K=ZF42%W#M*4`UK9V/
MW(;-AQ'Y)'B;S\O$'H\O/'\G+RT/Q'$K2V;V?]0[C.G<DN=Q_P";FY]?G].7
M24/YP0/!U*!63L%Q^<HJR4([/\OC^?O9FX["<QCEG,QL*_C4VR!$5G,?-"HX
M:OS+%.)RD44(("`@(=0K5+<4FWI\B9=M1W,6/<*\LY:YS75-0',T([J@%;S[
M1AW;;XD0;RDLILJTT#[9KVL<T`4);)4AU:UH2%F>O"5T*,SFUXL..W-9=Q=4
M\F^QUEDS9NW3R5:C1FN[>E:D(@@6Y(9P9NC<":#0G;)JNW5*`%U.(%`M9:Z?
M=8]T;`:+*WY+K"\Q/H2$@"NIY'BI82[4Z.''358'ZJ^WS9/5-[LC=A]EN(M`
M_$P@$NY=!ZK#02`#0>9IX:Z44*\_^KAY72E5OS9Y%6&_BDCZLGD[:4S&R@@!
MAV'5;,'<FW04`NGX"QM!K/EO[I\(Z(?B\5<MGIJ&2,<WZ"X-)^H+5R[]D>YH
MYW-QV<LW6M="^*1CB/$-<\?Y17?L>_JXLDZDD'F8^2;95FV53$S"R[+6>NGC
M8#`*B`2\[,LS1ISAZ'*W7`/X->9E/=/"V(LP>)=ZA'S2R@`'OY6-=S?M-^*]
MK!>R6Y]4/W)G1Z7,*M@A<2X=W/)(.7X\CE8;XX\8,,\4[":X[PQ:36W(<A6Y
MI20/VW$Y<;YNF9,).?DP32._?*"<YA':4A1.;:4H"(5K#NK=^>WEDW9//3NE
MF)/*.#&`_98WL'#O.@J5N=L?8.V.GF&;A-KV[8+84YW'625P'SR.TYG'7N`J
M:`+8*K:5YJ.?G)Q\ROFF:L!W83=G)Q$2U=L9!@YD"LQ92#IR8Y)@Q%4Q(H@1
MJ/;,)1,I\A1JK&\-4C@25N%A'&R&(\6V?8*0H*+P<8`23AN'XMU+/5UG\FL"
MAB$47)\8Z.4AS@!A3*7H&F@4W&I)4P%`LK5!12B)1$&B+T%SVM;]YP4E;5TQ
M+&;A)9LJU>Q\@W2<H*)JE,7>4%2&[2Z6NY-0NBB1P`Q1`P`-1!H:J!%1113Y
M/\;LZUDAE\,7:S!`%3+I0UT.WD>\8&`=Y`8S4>U>F6$INA`.1,2Z`.X1]*K9
M!]H*4L/85_*VVGD;QTD$,SCW]X1Z!`2;J2LK;\\"92#M`Q).9>H2R@;0Z`<1
M``]JC]R=2@YPN]1UZ^1$ZW]/QXU32_[-I?)_HRPCZT^X\4\ZR=%73S.4*49*
MS6Z0]-VA;=^[^!(#3[GQ3SK($=/<F#B7XZVD4PZ;ND-T^7\%X/M5.C.]1JY=
MS92V;3:?%PB9?E_LWY_X+D:C1G>H>==F;2&31V_$19`U_"`/@OM>RW2H>2G;
M51\W@O>(N[U'3NL@`/?HV_S*^]2Z5\%'7Z%[-->Y1_E&V@=!]$=?3J`Z*#32
MGBHKSR*3'[Y+Y/9(?MZ?2J"AK7P7DD4D!_#2TZ![$]?V?:HFG8FJ\H#./<OW
M@_;J"BOUN6_@_>HB\@/0-?7WHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B
M)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*
((E$2B)1%_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
